Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Casale

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
Postgraduate Medicine|August 12, 2009
Small airway asthma therapy, challenges, and the futureThomas B Casale
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Omalizumab for chronic urticariaThomas B Casale
The Journal of Allergy and Clinical Immunology|November 20, 2024
Omalizumab: The journey of the first anti-IgE approved for asthma and allergic disordersThomas B Casale
The Journal of Allergy and Clinical Immunology|September 30, 2022
Novel biologics for treatment of chronic spontaneous urticariaThomas B Casale
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitisThomas B Casale,
The Journal of Allergy and Clinical Immunology|June 23, 2004
Status of immunotherapy: current and futureThomas B Casale
Postgraduate Medicine|August 12, 2009
Small airway inflammation: a new therapeutic target in asthma. IntroductionThomas B Casale
Postgraduate Medicine|August 12, 2009
The pathophysiology of small airway inflammation in asthmaThomas B Casale
The Journal of Allergy and Clinical Immunology. in Practice|July 13, 2015
COPD: The Not So Good, the Bad, and the Ugly!Thomas B Casale
Postgraduate Medicine|August 12, 2009
Asthma: imaging of the smaller airwaysThomas B Casale
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
Postgraduate Medicine|August 12, 2009
Small airway asthma therapy, challenges, and the futureThomas B Casale
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Omalizumab for chronic urticariaThomas B Casale
The Journal of Allergy and Clinical Immunology|November 20, 2024
Omalizumab: The journey of the first anti-IgE approved for asthma and allergic disordersThomas B Casale
The Journal of Allergy and Clinical Immunology|September 30, 2022
Novel biologics for treatment of chronic spontaneous urticariaThomas B Casale
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitisThomas B Casale,
The Journal of Allergy and Clinical Immunology|June 23, 2004
Status of immunotherapy: current and futureThomas B Casale
Postgraduate Medicine|August 12, 2009
Small airway inflammation: a new therapeutic target in asthma. IntroductionThomas B Casale
Postgraduate Medicine|August 12, 2009
The pathophysiology of small airway inflammation in asthmaThomas B Casale
The Journal of Allergy and Clinical Immunology. in Practice|July 13, 2015
COPD: The Not So Good, the Bad, and the Ugly!Thomas B Casale
Postgraduate Medicine|August 12, 2009
Asthma: imaging of the smaller airwaysThomas B Casale
Pageof 26